Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04254601Completed
Randomised, open-label trial in acne vulgaris (3 arms), sponsored by Cairo University. Primary endpoint: formal counts of active acne lesions at 8 weeks. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04254601.